Brad Hartman was Appointed as VP, People at resTORbio

Date of management change: August 02, 2019 

What Happened?

Boston, MA-based resTORbio Appointed Brad Hartman as VP, People


About the Company

resTORbio, Inc. is a clinical stage company, developing medicines to treat aging-related diseases and conditions. resTORbio`s lead program targets the mechanistic target of rapamycin complex 1 (mTORC1) pathway to treat aging-related diseases and conditions. Initially, resTORbio is focused on developing medicines that address conditions caused by immunosenescence, the decline in immune function due to aging. resTORbio has initiated a Phase 2b trial for its lead product candidate, RTB101, evaluating its potential to reduce the incidence of respiratory tract infections (RTI) in elderly individuals at increased risk of RTI-related morbidity and mortality. resTORbio`s lead program is built upon two Phase 2a clinical studies demonstrating promising safety and efficacy results in almost 500 elderly individuals.


About the Person

Brad Hartman is VP, People at resTORbio. Previously, Brad held various senior HR leadership roles in the industry.


Info Source



Other IT executives who recently changed jobs as well: Striebig Lisa, Esquet Yvonne, Brickhead Kent, Hammitt Heather, Schwarz Deborah, Sciabarasi Suzin, Rivera Jennifer, Astrup Kristina, Lukes Molly, Whitehill Christine, Bozeman Ann

You can find the full directory of IT executives here.

How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.